Zhang Zhiyao, Li Zhenyu, Chen Wenming
Department of Hematology, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, P.R. China.
Department of Hematology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, P.R. China.
Exp Ther Med. 2018 Nov;16(5):4253-4259. doi: 10.3892/etm.2018.6722. Epub 2018 Sep 11.
G protein-coupled receptor kinase 6 (GRK6) is highly expressed in multiple myeloma (MM) cell lines, but absent or only weakly expressed in most primary human somatic cells. In the present study, GRK6 expression was assessed in MM patients and healthy individuals by quantitative polymerase chain reaction. Flow cytometry were performed to measure the apoptosis of lentivial-transfected MM1R cells. Western blot analysis was performed to assess the apoptosis and signal transducer and activator of transcription 3 pathway-related factors. The results demonstrated that GRK6 was differentially expressed in individuals who suffered from MM and healthy individuals. Previous studies have shown that downregulating GRK6 has anti-cancer effects in the MM cell line, MM1R. The present study demonstrated that RNA interference-mediated GRK6 knockdown promoted apoptosis in the MM1R cell line. Therefore, we hypothesized that GRK6 plays a significant role in determining the course of MM.
G蛋白偶联受体激酶6(GRK6)在多发性骨髓瘤(MM)细胞系中高表达,但在大多数原代人体细胞中不存在或仅微弱表达。在本研究中,通过定量聚合酶链反应评估了MM患者和健康个体中GRK6的表达。进行流式细胞术以测量慢病毒转染的MM1R细胞的凋亡。进行蛋白质免疫印迹分析以评估凋亡以及转录信号转导子和激活子3通路相关因子。结果表明,GRK6在MM患者和健康个体中差异表达。先前的研究表明,下调GRK6在MM细胞系MM1R中具有抗癌作用。本研究表明,RNA干扰介导的GRK6敲低促进了MM1R细胞系中的细胞凋亡。因此,我们推测GRK6在决定MM病程中起重要作用。